These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 30182208)
1. Relapse patterns in patients with local and regional cutaneous melanoma. Tas F; Erturk K Clin Transl Oncol; 2019 Apr; 21(4):412-419. PubMed ID: 30182208 [TBL] [Abstract][Full Text] [Related]
2. Early and late relapses of cutaneous melanoma patients. Tas F; Erturk K Postgrad Med; 2019 Apr; 131(3):207-211. PubMed ID: 30644788 [TBL] [Abstract][Full Text] [Related]
3. Malignant melanoma in Turkey: a single institution's experience on 475 cases. Tas F; Kurul S; Camlica H; Topuz E Jpn J Clin Oncol; 2006 Dec; 36(12):794-9. PubMed ID: 17060409 [TBL] [Abstract][Full Text] [Related]
4. Recurrence behavior in early-stage cutaneous melanoma: pattern, timing, survival, and influencing factors. Tas F; Erturk K Melanoma Res; 2017 Apr; 27(2):134-139. PubMed ID: 28099368 [TBL] [Abstract][Full Text] [Related]
5. Recurrent malignant melanoma: the identification of prognostic factors to predict survival. Reintgen DS; Cox C; Slingluff CL; Seigler HF Ann Plast Surg; 1992 Jan; 28(1):45-9. PubMed ID: 1642405 [TBL] [Abstract][Full Text] [Related]
6. Presence of histological regression as a prognostic factor in cutaneous melanoma patients. Tas F; Erturk K Melanoma Res; 2016 Oct; 26(5):492-6. PubMed ID: 27380112 [TBL] [Abstract][Full Text] [Related]
7. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma. Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606 [TBL] [Abstract][Full Text] [Related]
8. Histological lymphovascular invasion is associated with nodal involvement, recurrence, and survival in patients with cutaneous malignant melanoma. Tas F; Erturk K Int J Dermatol; 2017 Feb; 56(2):166-170. PubMed ID: 27778319 [TBL] [Abstract][Full Text] [Related]
9. Margins of excision for cutaneous melanoma of the eyelid skin: the Collaborative Eyelid Skin Melanoma Group Report. Esmaeli B; Youssef A; Naderi A; Ahmadi MA; Meyer DR; McNab A; Ophthalmic Plast Reconstr Surg; 2003 Mar; 19(2):96-101. PubMed ID: 12644753 [TBL] [Abstract][Full Text] [Related]
10. Pathologic and clinical features influencing outcome of thin cutaneous melanoma: correlation with newly proposed staging system. Finley JW; Gibbs JF; Rodriguez LM; Letourneau R; Driscoll D; Kraybill W Am Surg; 2000 Jun; 66(6):527-31; discussion 531-2. PubMed ID: 10888127 [TBL] [Abstract][Full Text] [Related]
11. Different mitotic rates are associated with different prognostic factors, relapses, and survival rates in melanoma. Tas F; Erturk K Int J Dermatol; 2022 Apr; 61(4):472-479. PubMed ID: 34633070 [TBL] [Abstract][Full Text] [Related]
12. [Descriptive analysis of cutaneous recurrence patterns in patients with melanoma]. Marcoval J; Ferreres JR; Penín RM; Piulats JM; Caminal JM; Fabra A Actas Dermosifiliogr; 2011 Dec; 102(10):791-6. PubMed ID: 21658662 [TBL] [Abstract][Full Text] [Related]
13. Prospective evaluation of prognostic indicators for early recurrence of cutaneous melanoma. Matheson JA; Te Marvelde L; Mailer S; Speakman D; Spillane J; Henderson MA; Gyorki DE Melanoma Res; 2017 Feb; 27(1):43-49. PubMed ID: 27753732 [TBL] [Abstract][Full Text] [Related]
14. A retrospective multicenter evaluation of cutaneous melanomas in Turkey. Gamsizkan M; Yilmaz I; Buyukbabani N; Demirkesen C; Demiriz M; Cetin ED; Ince U; Akalin T; Demirkan NC; Lebe B; Erdem O; Gokoz O; Sakiz D; Demireli PT; Astarci HM; Adim SB; Zemheri IE; Acikalin A; Yaman B; Aydin O; Bassorgun CI Asian Pac J Cancer Prev; 2014; 15(23):10451-6. PubMed ID: 25556491 [TBL] [Abstract][Full Text] [Related]
15. Clinical and pathologic factors associated with distant metastasis and survival in patients with thin primary cutaneous melanoma. Murali R; Haydu LE; Long GV; Quinn MJ; Saw RP; Shannon K; Spillane AJ; Stretch JR; Kefford RF; Thompson JF; Scolyer RA Ann Surg Oncol; 2012 Jun; 19(6):1782-9. PubMed ID: 22350600 [TBL] [Abstract][Full Text] [Related]
16. Scalp melanoma is associated with high mitotic rate and is a poor prognostic factor for recurrence and outcome. Tas F; Erturk K Melanoma Res; 2017 Aug; 27(4):387-390. PubMed ID: 28234768 [TBL] [Abstract][Full Text] [Related]
17. Prognosis and determinants of outcome following locoregional or distant recurrence in patients with cutaneous melanoma. Francken AB; Accortt NA; Shaw HM; Wiener M; Soong SJ; Hoekstra HJ; Thompson JF Ann Surg Oncol; 2008 May; 15(5):1476-84. PubMed ID: 18196345 [TBL] [Abstract][Full Text] [Related]
19. Mitotic rate and subcutaneous involvement are prognostic factors for survival after recurrence in patients with only locoregional skin metastasis as the first site of recurrence from cutaneous melanoma. Messeguer F; Agustí-Mejías A; Traves V; Requena C; Alegre V; Guillén C; Oliver V; Nagore E J Eur Acad Dermatol Venereol; 2013 Apr; 27(4):436-41. PubMed ID: 22303982 [TBL] [Abstract][Full Text] [Related]
20. Pattern and incidence of first site recurrences following sentinel node procedure in melanoma patients. Statius Muller MG; van Leeuwen PA; van Diest PJ; Pijpers R; Nijveldt RJ; Vuylsteke RJ; Meijer S World J Surg; 2002 Dec; 26(12):1405-11. PubMed ID: 12297910 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]